Organization · Venture Capital
PBM Capital Group
PBM Capital Group is a healthcare-focused venture capital firm based in Charlottesville, Virginia, investing in pharmaceutical and life sciences companies. The firm partners with scientists and entrepreneurs to develop innovative therapies.
Overview
What PBM Capital Group does
What PBM Capital Group is
PBM Capital Group is a healthcare-focused venture capital firm based in Charlottesville, Virginia, investing in pharmaceutical and life sciences companies. The firm partners with scientists and entrepreneurs to develop innovative therapies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find PBM Capital Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
PBM Capital Group as a funder
Investment thesis
PBM Capital Group partners with exceptional scientists, engineers, and entrepreneurs developing game-changing pharmaceutical and biological technologies. The firm emphasizes operational capabilities and expertise to help portfolio companies create life-changing products.
Focus narrative
PBM Capital invests in the pharmaceutical and life sciences sectors, supporting companies led by entrepreneurs whose aspirations align with its investment thesis. The firm emphasizes the importance of operational capabilities and expertise to help portfolio companies develop revolutionary products.
Value beyond capital
PBM Capital Group brings proven operational capabilities and hands-on expertise to its portfolio companies, focusing on building platform operating companies and life-changing pharmaceutical and biological products.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 13
- Recorded notable exits
- AveXis, Dova Pharmaceuticals, and Verrica Pharmaceuticals
Portfolio context
Notable portfolio companies include: AveXis: Acquired by Novartis, focused on gene therapies. Dova Pharmaceuticals: Specializes in treatments for rare diseases. Verrica Pharmaceuticals: Develops therapies for dermatological conditions. Candel Therapeutics: Works on viral immunotherapy platforms. Taysha Gene Therapies: Focuses on gene therapies for neurological diseases. Lexeo Therapeutics: Engages in gene therapy development. Saliogen Therapeutics: Develops gene therapies for various conditions.
Common questions
What to know about PBM Capital Group
Upseed classifies PBM Capital Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.